Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Poxviruses are widely used for the cytoplasmic expression of recombinant genes in mammalian cells. Recent improvements allow high expression and simplify the integration of multiple foreign genes. Vaccinia virus mutants and other poxviruses that undergo abortive infection in mammalian cells are receiving special attention because of their diminished cytopathic effects and increased safety. New replicating and 'non-replicating' vectors, encoding the bacteriophage T7 RNA polymerase for transcription of recombinant genes, have been engineered.

Original publication

DOI

10.1016/s0958-1669(97)80031-6

Type

Journal article

Journal

Current opinion in biotechnology

Publication Date

10/1997

Volume

8

Pages

573 - 577

Addresses

Oxford BioMedica (UK) Ltd, Medawar Centre.

Keywords

Cells, Cultured, Animals, Mammals, Humans, Poxviridae, Vaccinia virus, Recombinant Proteins, Recombinant Fusion Proteins, Transfection, Biotechnology, Virus Replication, Genetic Vectors, Promoter Regions, Genetic